Internal Medicine, Endocrinology, Diabetes, & Metabolism · Modesto, CA
NPI
1215025465
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1541 Florida Ave, Ste #200
Modesto, CA, 95350
Phone (209) 577-3388
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
2,168 services
Medicare patients, 2024
376
Average age 69
Drug cost, 2024
$2.7M
6,287 prescriptions
Company payments, 2025
$85.68
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ricky Bassi was code J0897 (injection, denosumab, 1 mg), 1,081 times for 12 patients. In total Ricky Bassi billed 2,168 services in 15 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,081 | 12 | $20.76 | $22K |
| 99214 Office E&M - Established | Office | 334 | 223 | $86.74 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 277 | 213 | $11.45 | $3,173 |
| 99213 Office E&M - Established | Office | 199 | 167 | $60.90 | $12K |
| 95251 Test - Miscellaneous | Office | 138 | 82 | $25.75 | $3,554 |
| 99204 Office E&M - New | Office | 23 | 23 | $102.33 | $2,354 |
| 83036 Blood Count | Office | 22 | 21 | $9.52 | $209 |
| 96372 Injection Administration | Office | 20 | 13 | $11.67 | $233 |
| 99442 Telephone Services | Office | 19 | 19 | $65.08 | $1,236 |
| 76536 Ultrasound - Nonspecific | Office | 17 | 16 | $76.79 | $1,305 |
| 99205 Office E&M - New | Office | 14 | 14 | $151.53 | $2,121 |
By year: 2022 $73K for 2,013 services; 2023 $70K for 1,996 services; 2024 $80K for 2,168 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 22 | 21 | $9.52 | $209 |
Medicare prescription drug claims, 2024
In 2024, the drug Ricky Bassi prescribed most often to Medicare patients was Levothyroxine Sodium, with 828 prescriptions and refills. In total Ricky Bassi wrote 6,287 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 828 | 2,370 | 249 | $14K |
| Jardiance Empagliflozin | 377 | 829 | 105 | $452K |
| Ozempic Semaglutide | 357 | 568 | 76 | $526K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 266 | 685 | 103 | $31K |
| Humalog Kwikpen U-100 Insulin Lispro | 247 | 467 | 72 | $68K |
| Metformin Hcl Generic | 245 | 686 | 74 | $2,813 |
| Humulin N Kwikpen Insulin Nph Human Isophane | 192 | 422 | 66 | $50K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 185 | 415 | 63 | $29K |
| Glimepiride Generic | 172 | 491 | 62 | $2,472 |
| Rybelsus Semaglutide | 169 | 378 | 59 | $335K |
| Methimazole Generic | 152 | 436 | 50 | $2,821 |
| Glipizide Generic | 136 | 359 | 54 | $1,578 |
| Alendronate Sodium Generic | 126 | 352 | 40 | $1,765 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 112 | 216 | 31 | $56K |
| Atorvastatin Calcium Generic | 97 | 275 | 33 | $919 |
Brand drugs: 3,243 claims; generic drugs: 2,477 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ricky Bassi $85.68 ($85.68 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $85.68.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $85.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.